BioCryst Pharmaceuticals
BCRX
#5073
Rank
S$2.07 B
Marketcap
S$9.86
Share price
-0.33%
Change (1 day)
-4.86%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total debt

Total debt on the balance sheet as of September 2025 : S$0.83 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total debt is S$0.83 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BioCryst Pharmaceuticals - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$1.09 B0.87%
2023-12-31S$1.08 B9.64%
2022-12-31S$0.99 B23.94%
2021-12-31S$0.80 B116.9%
2020-12-31S$0.36 B223.99%
2019-12-31S$0.11 B35.13%
2018-12-31S$84.45 M15.4%
2017-12-31S$73.19 M-5.87%
2016-12-31S$77.75 M82.14%
2015-12-31S$42.68 M7.69%
2014-12-31S$39.64 M4.29%
2013-12-31S$38 M3.6%
2012-12-31S$36.68 M-5.57%
2011-12-31S$38.85 M
2000-12-31S$0.01 M
1997-12-31S$0.16 M-59.84%
1996-12-31S$0.41 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Repligen
RGEN
S$0.89 B 6.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S$1.61 B 93.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
S$1.94 M-99.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
S$0.32 B-61.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$32.28 B 3,764.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$3.39 M-99.59%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$30.88 B 3,597.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
S$0.85 B 2.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S$12.89 M-98.46%๐Ÿ‡บ๐Ÿ‡ธ USA